SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (2570)11/7/2018 11:18:18 AM
From: DewDiligence_on_SI  Read Replies (2) | Respond to of 3559
 
The 8% (pre-tax) royalty equates to about 6% after-tax. Moreover, this rate is for only 4 yrs; after 2023, the Libtayo royalty is de minimis.



To: Miljenko Zuanic who wrote (2570)11/7/2018 11:24:58 AM
From: tuck  Read Replies (1) | Respond to of 3559
 
Anyway, looks like REGN will pay ROYALTY on any and every their candidate! How that speak for their "Frontier Science*?
Well, at least their scientists can tell the business development team what to license. And at least they're not doing stock buybacks. :>)

Cheers, Tuck